Published online May 16, 2021. doi: 10.12998/wjcc.v9.i14.3334
Peer-review started: September 28, 2020
First decision: December 14, 2020
Revised: December 24, 2020
Accepted: January 7, 2021
Article in press: January 7, 2021
Published online: May 16, 2021
Processing time: 212 Days and 20.3 Hours
The metastasis of liver cancer to skeletal muscle is extremely rare compared to other sites. We herein report a case of rapidly developing skeletal metastases following liver transplantation due to primary liver cancer.
A 70-year-old male with underlying chronic hepatitis B virus infection was diagnosed with hepatocellular carcinoma (HCC), for which he underwent liver transplantation in 2014. Six years after receiving the transplant, pathological examination confirmed the presence of HCC without vascular invasion. He was admitted to the hospital with a rapidly growing mass on his right thigh. Ultrasound examination revealed a mixed echo mass in the lateral soft tissue of the middle part of the right femur. Magnetic resonance imaging showed heterogeneous iso-signal intensity on T1-weighted images and heterogeneous hyper-intensity on T2-weighted images compared to the surrounding muscles. Pathological examination of the ultrasound-guided needle biopsy specimen revealed that it was similar to the previously detected liver cancer; the diagnosis was metastasis of HCC. Surgical excision was performed. There were no other sites of metastasis, and the patient recovered well after surgery.
This report presents a rare case of skeletal metastasis following liver transplant
Core Tip: Skeletal muscle metastasis from hepatocellular carcinoma is extremely rare and is often accompanied by metastasis to other organs. We herein report a case of rapidly developing skeletal metastases after liver transplantation due to primary liver cancer, without any other organ metastases. There is a dearth of literature on the detailed prognosis of patients with skeletal muscle metastasis. Therefore, the correct interpretation of the molecular and pathophysiological mechanisms of skeletal muscle metastasis may help with the development of novel therapies to combat the progression of the disease.